Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan

International Journal of Hematology

Volumn 89, Issue 5, 2009, Pages 649-655

  Ohta, Kensuke ^a   Nishiki Kosaka, Saori ^a   Nakao, Yoshitaka ^b   Kumura, Takeo ^c   Hagihara, Kiyomichi ^b   Sakamoto, Erina ^d   Okamoto, Shuichiro ^a   Hirose, Asao ^b   Aoyama, Yasutaka ^c   Yamamura, Ryousuke ^a   Hayashi, Yoshiki ^d   Umemoto, Yukari ^b   Terada, Yoshiki ^e   Takeoka, Yasunobu ^e   Nakane, Takahiko ^e   Koh, Hideo ^e   Hino, Masayuki ^e  

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

^b Wakakokai Hospital   (Japan)

^c Fuchu Hospital   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Deep fungal infection; Empirical antifungal therapy; EORTC MSG criteria; Febrile neutropenia; Itraconazole

Indexed keywords

ITRACONAZOLE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHILL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DYSPNEA; FEMALE; FEVER; HEMATOLOGIC DISEASE; HUMAN; HYPOXEMIA; JAPAN; LUNG LESION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; NEUTROPENIA; RASH; RIGOR; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DRUG TOXICITY; FEMALE; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; ITRACONAZOLE; MALE; MIDDLE AGED; NEUTROPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67749127245     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0316-3     Document Type: Article

References (19)

1. H Kume T Yamazaki M Abe H Tanuma M Okudaira I Okayasu 2006 Epidemiology of visceral mycoses in patients with leukemia and MDS-Analysis of the data in annual of pathological autopsy cases in Japan in 1989, 1993, 1997 and 2001- Jpn J Med Mycol 47 15 24
2. JR Wingard 1995 Importance of Candida species other than C. albicans as pathogens in oncology patients Clin Infect Dis 20 115 25
3. Committee making guideline of systemic fungal infections editors: guidelines for diagnosis and treatment and of systemic fungal infections 2007. Tokyo: Kyowakikaku; 2007.
4. EORTC international antimicrobial therapy cooperative group: empiric antifungal therapy in febrile granulocytopenic patients. Am J Med. 1989;86:668-72. doi: 10.1016/0002-9343(89)90441-5. (Pubitemid 19149347)
5. M Booraerts DJ Winston EJ Bow G Garber AC Reboli AP Schwarer 2001 Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy A randomized, controlled trial. Ann Intern Med 135 412 22
6. U Schuler S Bammer WE AUulitzky C Binder A Bohme G Egerer 2007 Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy Onkologie 301 185 91 10.1159/000100055 (Pubitemid 46482161)
7. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002;346:s225-34. doi: 10.1056/NEJM200201243460403. (Pubitemid 34438861)
8. ER Kuse P Chetchotisakd CA da Cunha M Ruhnke C Barrios D Raghunadharao 2007 Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Lancet 369 1519 27 10.1016/S0140-6736(07)60605-9 (Pubitemid 46670281)
9. TJ Walsh H Tapplar GR Donowitz JA Maertens LR Baden A Dmoszynska 2004 Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia N Engl J Med 351 1391 402 10.1056/NEJMoa040446 (Pubitemid 39288165)
10. JH Rex MA Pfaller JN Galgiani MS Bartlett A Espinel-Ingroff MA Ghannoum 1997 Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 24 235 47
11. CR Bradford AG Prentice DW Warnock JA Copplestone 1991 Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia J Antimicrob Chemother 28 555 60 10.1093/jac/28.4.555
12. PG Pappas JH Rex JD Sobel SG Filler WE Dismukes TJ Walsh 2004 Guidelines for treatment of candidiasis Clin Infect Dis 15 161 89 10.1086/380796 (Pubitemid 38113025)
13. S Kohno H Yamaguchi T Mori H Hirai M Oritsu Y Niki 2006 Efficacy and safety of Itraconazole injections and capsules in deep mycosis Jpn J Chemother 54 Suppl. 1 32 47
14. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14. doi: 10.1086/323335. (Pubitemid 33152659)
15. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-21. doi: 10.1086/588660.
16. L Corey M Boeckh 2002 Persistent fever in patients with neutropenia N Engl J Med 346 222 4 10.1056/NEJM200201243460402 (Pubitemid 34438860)
17. A Busca F Locatelli A Barbui G Limerutti R Serra D Libertucci 2006 Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation Transplant Proc 38 1610 3 10.1016/j.transproceed.2006.02.072 (Pubitemid 43912722)
18. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis. 2005; 41:1242-50.
19. Oshima K, Kanda Y, Asano-Mori Y, Nishimoto N, Arai S, Nagai S, et al. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2007; 60:350-5.